Skip to main content
InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
9.21
+0.19 (2.11%)
Nov 21, 2024, 11:19 AM EST - Market open

InfuSystem Holdings Revenue

InfuSystem Holdings had revenue of $35.32M in the quarter ending September 30, 2024, with 10.69% growth. This brings the company's revenue in the last twelve months to $132.78M, up 8.17% year-over-year. In the year 2023, InfuSystem Holdings had annual revenue of $125.79M with 14.44% growth.

Revenue (ttm)
$132.78M
Revenue Growth
+8.17%
P/S Ratio
1.44
Revenue / Employee
$257,333
Employees
516
Market Cap
191.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023125.79M15.87M14.44%
Dec 31, 2022109.91M7.53M7.36%
Dec 31, 2021102.38M5.79M5.99%
Dec 31, 202096.60M15.52M19.14%
Dec 31, 201981.08M13.94M20.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nektar Therapeutics 93.14M
Sight Sciences 79.54M
ADC Therapeutics 70.72M
Cellectis 36.04M
Jin Medical International 20.13M
Profound Medical 8.98M
Orchestra BioMed Holdings 2.65M
Revenue Rankings

INFU News

More News